BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10202236)

  • 1. New strategies for allogeneic bone marrow transplantation and organ allografts.
    Ikehara S
    Acta Haematol; 1999; 101(2):68-77. PubMed ID: 10202236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation for autoimmune diseases.
    Ikehara S
    Acta Haematol; 1998; 99(3):116-32. PubMed ID: 9587393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New method for thyroid transplantation across major histocompatibility complex barriers using allogeneic bone marrow transplantation.
    Lee S; Sugiura K; Nagahama T; Iwai H; Yasumizu R; Yamashita T; Ikehara S
    Transplantation; 2001 Sep; 72(6):1144-9. PubMed ID: 11579314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation: a new strategy for intractable diseases.
    Ikehara S
    Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel strategy for organ allografts using sublethal (7 Gy) irradiation followed by injection of donor bone marrow cells via portal vein.
    Jin T; Toki J; Inaba M; Sugiura K; Fan T; Yu C; Lian Z; Takase K; Feng B; Ito T; Cui Y; Yang G; Ikehara S
    Transplantation; 2001 Jun; 71(12):1725-31. PubMed ID: 11455249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategies for allogeneic BMT.
    Ikehara S
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S73-5. PubMed ID: 12931248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful allogeneic leg transplantation in rats in conjunction with intra-bone marrow injection of donor bone marrow cells.
    Esumi T; Inaba M; Ichioka N; Kushida T; Iida H; Ikehara S
    Transplantation; 2003 Dec; 76(11):1543-8. PubMed ID: 14702521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New strategies for BMT, organ transplantation, and regeneration therapy.
    Ikehara S
    Hematology; 2003 Apr; 8(2):77-81. PubMed ID: 12745656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
    Kaneda H; Adachi Y; Saito Y; Ikebukuro K; Machida H; Suzuki Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Wang J; Imamura H; Ikehara S
    J Heart Lung Transplant; 2005 Sep; 24(9):1415-23. PubMed ID: 16143265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.
    Good RA
    World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New strategies for BMT and organ transplantation.
    Ikehara S
    Int J Hematol; 2002 Aug; 76 Suppl 1():161-4. PubMed ID: 12430846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful allogeneic bone marrow transplantation. Crucial roles of stromal cells in prevention of graft rejection.
    Ikehara S
    Acta Haematol; 2001; 105(3):172-8. PubMed ID: 11463992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantation across major histocompatibility barriers: persistent or redeveloping immunologic responsiveness after prolonged survival.
    Sugiura K; Yasumizu R; Iwai H; Inaba MM; Toki J; Ogura M; Hara I; Good RA; Ikehara S
    Thymus; 1991 Nov; 18(3):137-53. PubMed ID: 1838450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New strategies for BMT].
    Ikehara S
    Nihon Rinsho; 2002 Dec; 60(12):2310-7. PubMed ID: 12510355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term (>1 year) analyses of chimerism and tolerance in mixed allogeneic chimeric mice using normal mouse combinations.
    Hayashi H; Toki J; Zhexiong L; Sugiura K; Inoue K; Ikehara S
    Stem Cells; 2000; 18(4):273-80. PubMed ID: 10924093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitation of hematopoietic recovery by bone grafts with intra-bone marrow-bone marrow transplantation.
    Song C; Hisha H; Wang X; Li Q; Li M; Cui W; Guo K; Okazaki S; Mizokami T; Kato J; Cui Y; Feng W; Zhang Y; Shi M; Inaba M; Fan H; Ikehara S
    Immunobiology; 2008; 213(6):455-68. PubMed ID: 18514748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.